Detalhe da pesquisa
1.
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.
Proc Natl Acad Sci U S A
; 120(33): e2300343120, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566635
2.
Guidelines for mouse and human DC generation.
Eur J Immunol
; 53(11): e2249816, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36303448
3.
Tumor Antigens beyond the Human Exome.
Int J Mol Sci
; 25(9)2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38731892
4.
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy.
Int J Mol Sci
; 24(3)2023 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768665
5.
Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases.
Int J Mol Sci
; 23(15)2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955729
6.
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.
Int J Mol Sci
; 22(16)2021 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445385
7.
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation.
Int J Mol Sci
; 22(21)2021 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769379
8.
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells.
Int J Mol Sci
; 22(19)2021 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638566
9.
CARs: Beyond T Cells and T Cell-Derived Signaling Domains.
Int J Mol Sci
; 21(10)2020 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32429316
10.
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges.
Int J Mol Sci
; 20(23)2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31779130
11.
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia.
Int J Mol Sci
; 20(11)2019 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195686
12.
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
Exp Dermatol
; 27(7): 769-778, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704887
13.
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma.
Int J Mol Sci
; 19(8)2018 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30103488
14.
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy.
Int J Mol Sci
; 19(1)2018 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346301
15.
Proteomic Response of Human Umbilical Vein Endothelial Cells to Histamine Stimulation.
Proteomics
; 17(21)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28921918
16.
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/ß T-cell receptor: a safer alternative to genetically engineered α/ß T cells for the immunotherapy of melanoma.
BMC Cancer
; 17(1): 551, 2017 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818060
17.
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma.
Exp Dermatol
; 25(11): 872-879, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27246630
18.
Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.
Eur J Immunol
; 44(12): 3543-59, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211552
19.
Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.
Eur J Immunol
; 44(11): 3413-28, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25100611
20.
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.
Cancer Immunol Immunother
; 64(12): 1623-35, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26515978